Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

著者: Fabrice André, Ruth O’Regan, Mustafa Özgüroğlu, Masakazu Toi, Binghe Xu, Guy Jérusalem, Norikazu Masuda, Sharon Wilks, Francis P. Arena, Claudine Isaacs, Yoon Sim Yap, Zsuzsanna Pápai, István Láng, Anne Armstrong, Guillermo Lerzo, Michelle White, Kunwei Shen, Jennifer K. Litton, David Chen, Yufen Zhang, Shyanne Ali, Tetiana Taran, Luca Gianni - The Lancet 2014 被引用: 491